JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for …

The TV1001SR IND was previously held by Soin Neuroscience, whose founder Dr. Amol Soin, now serves as JanOne's chief medical officer. Dr. Soin …

Link to Full Article: Read Here